Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Prospective Randomized Observer Blinded Single Center Study Comparing 90-day Functional Outcome in Patients Who Received Intravenous Propofol Infusion Versus Inhalational Sevoflurane for General Anesthesia During Mechanical Thrombectomy in Patients Who Suffered From Acute Ischemic Stroke

Key facts

Where
Kansas City, United StatesSee the site

Where in United States

  • University of Kansas Medical CenterKansas City, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Kansas Medical Center
Trial code
NCT07001267
Record updated
12 March 2026
Original description
This study is being done to compare outcomes after surgery for individuals who receive anesthesia through by inhaling medication and individuals who receive anesthesia intravenously by needle when experiencing treatment for their stroke. Currently very little is known about the outcomes for patients when comparing these two techniques of providing anesthesia during surgery. This study will provide information regarding outcomes that will help health care providers decide which technique will be better for patientsRead full original descriptionShow less

This study is being done to compare outcomes after surgery for individuals who receive anesthesia through by inhaling medication and individuals who receive anesthesia intravenously by needle when experiencing treatment for their stroke. Currently very little is known about the outcomes for patients when comparing these two techniques of providing anesthesia during surgery. This study will provide information regarding outcomes that will help health care providers decide which technique will be better for patients

Inclusion: >18 years Acute ischemic stroke requiring endovascular treatment.

Exclusion: Patients with malignant hyperthermia; Allergies or any contraindications to either inhalational or intravenous agents; <18 years; Pregnant patients; Patients already on intravenous anesthetic infusions; Prisoners; Students and employees.

ClinicalTrials.gov NCT07001267